Rituximab-induced Infusion Reaction Versus Infection: A Case of Fever with Chills During the First Infusion in Pemphigus Vulgaris with Concurrent Bacteriuria: A Case Report

Background: Rituximab is used as first-line therapy for moderate-to-severe pemphigus vulgaris, but fever occurring around an infusion may be difficult to distinguish from infection or another drug-related event. Case Presentation: A 59-year-old woman with relapsing pemphigus vulgaris was admitted with widespread flaccid bullae, oral involvement and positive Nikolsky and bulla-spread signs. She had been receiving prednisolone and dapsone. Before rituximab treatment, a urine culture grew Escherichia coli, and intravenous antibiotics were administered. During her first intravenous rituximab infusion of 1 g on 12 June 2026, she developed chills, a temperature of approximately 100°F and tachypnoea. The infusion was interrupted and restarted at 14:00, without further documented reaction. She remained afebrile for the rest of the observation period. Low-grade fever recurred between 15 and 18 June during antibiotic treatment. Blood cultures were advised but were not obtained because the family declined sampling. The fever resolved by 19 June. A second 1 g rituximab infusion was administered on 26 June with the same premedication and without a documented reaction. The initial event was reported to the Pharmacovigilance Programme of India, and a Naranjo score of 3 indicated a possible adverse drug reaction. Conclusion: The timing and resolution of the first episode support a mild infusion-related reaction, whereas the later febrile episodes remain difficult to attribute because bacteriuria and concurrent antibiotic treatment offered alternative explanations. Careful documentation of the clinical chronology is essential for cautious causality assessment.

Authors

Publication Details

Published
2026-11-13
DOI
https://doi.org/10.9734/ajcrmh/2026/v9i1361
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rituximab-induced Infusion Reaction Versus Infection: A Case of Fever with Chills During the First Infusion in Pemphigus Vulgaris with Concurrent Bacteriuria: A Case Report

Usha Thatha
1 links
Autoimmune Bullous Skin Diseases
article

Rituximab-induced Infusion Reaction Versus Infection: A Case of Fever with Chills During the First Infusion in Pemphigus Vulgaris with Concurrent Bacteriuria: A Case Report

Usha Thatha
article en

Abstract

Background: Rituximab is used as first-line therapy for moderate-to-severe pemphigus vulgaris, but fever occurring around an infusion may be difficult to distinguish from infection or another drug-related event. Case Presentation: A 59-year-old woman with relapsing pemphigus vulgaris was admitted with widespread flaccid bullae, oral involvement and positive Nikolsky and bulla-spread signs. She had been receiving prednisolone and dapsone. Before rituximab treatment, a urine culture grew Escherichia coli, and intravenous antibiotics were administered. During her first intravenous rituximab infusion of 1 g on 12 June 2026, she developed chills, a temperature of approximately 100°F and tachypnoea. The infusion was interrupted and restarted at 14:00, without further documented reaction. She remained afebrile for the rest of the observation period. Low-grade fever recurred between 15 and 18 June during antibiotic treatment. Blood cultures were advised but were not obtained because the family declined sampling. The fever resolved by 19 June. A second 1 g rituximab infusion was administered on 26 June with the same premedication and without a documented reaction. The initial event was reported to the Pharmacovigilance Programme of India, and a Naranjo score of 3 indicated a possible adverse drug reaction. Conclusion: The timing and resolution of the first episode support a mild infusion-related reaction, whereas the later febrile episodes remain difficult to attribute because bacteriuria and concurrent antibiotic treatment offered alternative explanations. Careful documentation of the clinical chronology is essential for cautious causality assessment.

Vol. 9(1)
Good health and well-being
Autoimmune Bullous Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon